Stanley Capital partners with AAICO

Stanley Capital has partnered with Applied Artificial Intelligence Corporation (AAICO) to support its value creation efforts. 

Founded in 2021, AAICO applies proprietary AI technology to drive value creation. 

This partnership enables Stanley Capital’s technology arm, Stanley Labs (S-Labs) to use AAICO’s AI technologies. S-Labs focuses on developing and using AI and automation products to create value within the firm, its healthcare services and software special purpose acquisition vehicle (SPAC) and its portfolio companies.

The pair previously partnered on Stanley’s $216m SPAC, healthcare AI acquisition corp, which listed on NASDAQ on 10 December 2021.

"Our overall investment process is anchored by our deep quantitative and fundamental research that will be significantly enhanced by our partnership with AAICO to apply AI automation to understanding and creating value across our portfolio," said Simon Cottle, founding partner at Stanley Capital.

"Our value creation partnership with Stanley Capital marks an important milestone for the private equity ecosystem, as one of the first alliances between a private equity fund and an AI technology firm," said Arya Bolurfrushan, founder and CEO of AAICO. "At AAICO, AI is not just a buzzword, rather we rigorously apply AI to repetitive, mission-critical processes to unlock value, and we look forward to exploring more opportunities to apply our AI technology across Stanley Capital's portfolio and investment pipeline."

Stanley Capital is a European and US focused mid-market PE firm, focused on resource efficiency, healthcare and technology investing.